BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16448546)

  • 1. Role of the transcription factor Th-POK in CD4:CD8 lineage commitment.
    Kappes DJ; He X; He X
    Immunol Rev; 2006 Feb; 209():237-52. PubMed ID: 16448546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
    He X; He X; Dave VP; Zhang Y; Hua X; Nicolas E; Xu W; Roe BA; Kappes DJ
    Nature; 2005 Feb; 433(7028):826-33. PubMed ID: 15729333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR and Notch signaling in CD4 and CD8 T-cell development.
    Laky K; Fleischacker C; Fowlkes BJ
    Immunol Rev; 2006 Feb; 209():274-83. PubMed ID: 16448548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commitment issues: linking positive selection signals and lineage diversification in the thymus.
    Aliahmad P; Kaye J
    Immunol Rev; 2006 Feb; 209():253-73. PubMed ID: 16448547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
    Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
    Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4-CD8 lineage commitment: an inside view.
    Kappes DJ; He X; He X
    Nat Immunol; 2005 Aug; 6(8):761-6. PubMed ID: 16034433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4/CD8 lineage commitment: light at the end of the tunnel?
    He X; Kappes DJ
    Curr Opin Immunol; 2006 Apr; 18(2):135-42. PubMed ID: 16480861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus.
    He X; Park K; Wang H; He X; Zhang Y; Hua X; Li Y; Kappes DJ
    Immunity; 2008 Mar; 28(3):346-58. PubMed ID: 18342007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor signals and nuclear events in CD4 and CD8 T cell lineage commitment.
    Laky K; Fowlkes BJ
    Curr Opin Immunol; 2005 Apr; 17(2):116-21. PubMed ID: 15766669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for sustained MAPK signaling in both CD4 and CD8 lineage commitment: a threshold model.
    Wilkinson B; Kaye J
    Cell Immunol; 2001 Aug; 211(2):86-95. PubMed ID: 11591112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent insights into the signals that control alphabeta/gammadelta-lineage fate.
    Lauritsen JP; Haks MC; Lefebvre JM; Kappes DJ; Wiest DL
    Immunol Rev; 2006 Feb; 209():176-90. PubMed ID: 16448543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signals involved in CD4/CD8 lineage commitment: current concepts and potential mechanisms.
    Singer A; Bosselut R; Bhandoola A
    Semin Immunol; 1999 Aug; 11(4):273-81. PubMed ID: 10441213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.
    Setoguchi R; Tachibana M; Naoe Y; Muroi S; Akiyama K; Tezuka C; Okuda T; Taniuchi I
    Science; 2008 Feb; 319(5864):822-5. PubMed ID: 18258917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The network of transcription factors that underlie the CD4 versus CD8 lineage decision.
    Naito T; Taniuchi I
    Int Immunol; 2010 Oct; 22(10):791-6. PubMed ID: 20732858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.
    Sato T; Chiba T; Ohno S; Sato C; Sugoh T; Miyashita K; Akatsuka H; Hozumi K; Okada Y; Iida Y; Akatsuka A; Agata Y; Chiba M; Kohu K; Satake M; Tanabe H; Saya H; Habu S
    J Immunol; 2012 Nov; 189(9):4426-36. PubMed ID: 23018457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic interplay between ThPOK and Runx in lineage choice of thymocytes.
    Egawa T; Taniuchi I
    Blood Cells Mol Dis; 2009; 43(1):27-9. PubMed ID: 19375362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular and molecular mechanism of CD4/CD8 lineage commitment.
    Yasutomo K
    J Med Invest; 2002 Feb; 49(1-2):1-6. PubMed ID: 11901754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell development and the CD4-CD8 lineage decision.
    Germain RN
    Nat Rev Immunol; 2002 May; 2(5):309-22. PubMed ID: 12033737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strength of signal: a fundamental mechanism for cell fate specification.
    Hayes SM; Love PE
    Immunol Rev; 2006 Feb; 209():170-5. PubMed ID: 16448542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.